Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixin Luo

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|September 29, 2025
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective studyWeixin Luo, Lixuan Liu, Wenping Lin, et al.
Bioengineering (Basel, Switzerland)|August 25, 2022
Bioinformatic Analysis and In Vitro and In Vivo Experiments Reveal That Fibrillarin Participates in the Promotion of Lung Metastasis in Hepatocellular CarcinomaWeixin Luo, Shusheng Lin, Yipei Huang, et al.
Oncogenesis|November 10, 2020
EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200cLeibo Xu, Junlong Lin, Wanyu Deng, et al.
Journal of Hepatocellular Carcinoma|August 11, 2021
DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular CarcinomaYiwen Guo, Weixin Luo, Shanzhou Huang, et al.
Journal of Cellular and Molecular Medicine|July 21, 2020
Systematic analysis on multiple Gene Expression Omnibus data sets reveals fierce immune response in hepatitis B virus-related acute liver failureHuadi Chen, Wenting Zhao, Yixi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
HBV-Specific TCR-T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regime for Recurrent HBV-Related HCC Post-Liver TransplantationQiang Zhao, Jinbo Huang, Weixin Luo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|September 29, 2025
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective studyWeixin Luo, Lixuan Liu, Wenping Lin, et al.
Bioengineering (Basel, Switzerland)|August 25, 2022
Bioinformatic Analysis and In Vitro and In Vivo Experiments Reveal That Fibrillarin Participates in the Promotion of Lung Metastasis in Hepatocellular CarcinomaWeixin Luo, Shusheng Lin, Yipei Huang, et al.
Oncogenesis|November 10, 2020
EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200cLeibo Xu, Junlong Lin, Wanyu Deng, et al.
Journal of Hepatocellular Carcinoma|August 11, 2021
DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular CarcinomaYiwen Guo, Weixin Luo, Shanzhou Huang, et al.
Journal of Cellular and Molecular Medicine|July 21, 2020
Systematic analysis on multiple Gene Expression Omnibus data sets reveals fierce immune response in hepatitis B virus-related acute liver failureHuadi Chen, Wenting Zhao, Yixi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
HBV-Specific TCR-T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regime for Recurrent HBV-Related HCC Post-Liver TransplantationQiang Zhao, Jinbo Huang, Weixin Luo, et al.
Pageof 2